Hide Board Information

Show Board Information

Karuna Therapeutics Inc. KRTX

Board Mod: Add me as mod

Asst Mods:

Last Post: 08/08/2022 5:06:57 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Karuna Therapeutics Inc. (NASDAQ: KRTX) Stock Message Board

1. KRTX Company Profile

    

2. KRTX Time & Sales

    

3. KRTX Recent News

    

4. KRTX Filings

    

5. KRTX Financials

    

6. KRTX Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

3	KRTX 71% v4,3M c241.19 f29,8M H245.0 ML122.59	znewcar1	08/08/2022 5:06:57 PM
2	KRTX 29% v5,5M c123.99 f23M started off slow then	znewcar1	11/19/2019 4:17:28 PM
1	KRTX 442% v15M c96 f23M H100 S78.77 gap up and	znewcar1	11/18/2019 10:32:51 PM

Recent Articles

• PBF Energy's Upcoming Participation in Noteworthy Conferences
• Marpai, Inc. Gears Up for Q3 Financial Results Webcast
• Ball Corporation Set to Showcase Innovations at Industry Conference
• Marriott International Announces New Cash Dividend for Investors
• Pangaea Logistics Solutions Q3 Results: Growth and Strategy Insights
• Exciting Business Updates and Q3 2025 Results from Precigen
• Huntsman Merges Financial Stability with Strong Dividend Policy
• Elevate Your Festive Spirit with Gemmy's Holiday Inflatables
• OppFi's Strategic Presentation at Investment Conference
• California Education Board Endorses Innovative IXL Program
• Pine Glo Launches Healing Initiative for Memory Care Facilities
• Unlocking the Future of Quantum Computing with Helios: A Game Changer
• Consolidated Edison Reports Increased Earnings for Q3 2025
• Codexis Announces Major Updates in Financial Reporting
• Golden Triangle Ventures Aims for Growth with Strategic Changes
• Datavault AI Revolutionizes Comedy with Innovative Partnership
• Valhi, Inc. Faces Challenges with Q3 2025 Results
• Valhi, Inc. Announces New Dividend Payment Details
• Brookdale Senior Living Enhances Guidance After Strong Q3 Results
• Nutanix Financial Report Preview and Upcoming Conference Call
• Robinhood Markets Set to Make Impactful Presentation Soon
• Drilling Tools International Corp. Delivers Solid Q3 2025 Gains
• Cytek Biosciences: Engaging Investors at Upcoming Events
• Social Governments Conference: A Vision for Tomorrow's Governance
• Upcoming Conference Call: Freehold Royalties Third Quarter Insights
• Abacus Global Management Unveils New Dividend and Buyback Plans
• Tharimmune Secures Major Funding to Propel Canton Network Strategy
• Huntsman Corporation Reports Mixed Financial Results for Q3 2025
• Trisura Group Reports Impressive Q3 2025 Financial Growth
• Cidara Therapeutics Reports Promising Advances and Q3 Results
• Rivermont Schools Appoints Emily Scott as New Principal
• Opendoor Technologies: Embracing AI for Future Profitability
• Tandem Diabetes Care, Inc. Faces Investigation Over Misleading Info
• CytomX Therapeutics Reports Strong Q3 2025 Results and Future Plans
• Applied Optoelectronics' Triumphant Third Quarter Financials
• Outstanding Growth for Monster Beverage in 2025 Q3 Results
• Nephros Delivers Remarkable Growth in Latest Financial Quarter
• CTO Realty Growth Celebrates Launch of Picklr at Forsyth
• Alexander & Baldwin Enhances Financial Structure with New Loan
• Motorsport Games Achieves Significant Growth in Q3 Results
• Flowers Foods: Navigating Challenges and Future Growth Planning
• Solventum Quarterly Financial Performance and Future Outlook
• Omada Health Achieves Impressive Growth and Innovation Milestones
• Natural Grocers Prepares for Q4 Earnings Call Amid Growth Drive
• Artivion's Impressive Q3 2025 Financial Performance Unveiled
• Omada Health Expands Prescribing Capability for GLP-1 Medications
• PDF Solutions Reports Impressive Growth in Q3 Financials
• Trevi Therapeutics Announces Q3 2025 Financial Update Plans
• Methode Electronics Set to Discuss Innovations at 2025 Conference
• 10x Genomics' Strong Q3 Performance Highlights Business Growth